Professor Frans Moll, University Medical Center Utrecht, will update an audience of international vascular surgeons at the VEITH Symposium in New York City this Saturday.
In a session on new technologies for vascular access creation, Professor Moll will provide an overview on the Xeltis polymer-based platform for endogenous tissue restoration, including insights from the ongoing clinical trials on the restorative vascular access graft for hemodialysis, aXess.
“Materials and technologies’ evolution enabled the development of devices that may substantially improve the way we treat hemodialysis patients and their overall experience in each dialysis session,” he explained. “I have been following this technology closely since its very early days in vascular surgery and I am delighted to present it now, as a clinical pivotal study is ongoing.”
Now in its 49th year, the VEITH Symposium provides vascular surgeons, interventional radiologists, interventional cardiologists and other vascular specialists with a unique format to learn the most current information about new and important treatments of vascular disease. The five-day event features presentations from world renowned vascular specialists with emphasis on the latest advances, changing concepts in diagnosis and management, pressing controversies and new techniques.